Please enter your AHPRA number to access the hub. For any further questions or support, please contact email@example.com or call 1800 288 382.
Fingolimod-Teva® is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
|PBS Information: Authority Required
Refer to PBS Schedule for full authority information
PLEASE REVIEW PRODUCT INFORMATION (PI) BEFORE PRESCRIBING.
Full PI can be accessed at https://rss.medsinfo.com.au/tb/pi.cfm?product=tbpfingo10123 or from Medical Information on 1800 AU TEVA (1800 288 382).
Date of preparation: May 2023, May 2023, GX-AU-00002.